A new drug known as D-512 is being developed at New York’s Binghamton University to treat Parkinson’s disease. It promises to limit the progression of Parkinson’s disease while also relieving symptoms more effectively than drugs currently available.About 60,000 Americans… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]
In the past, multiple sclerosis patients were advised not to exercise for fear of exacerbating the illness. However, it is now known that physical training can relieve many of the symptoms, including the excessive fatigue and mobility impairments that are often seen. New research now shows that resistance training may protect the nervous system and […]
Abstract This article describes a left-corner parser implemented within a cognitively and neurologically motivated distributed model of memory. This parser’s approach to syntactic ambiguity points toward a tidy account both of surprisal effects and of locality effects, such as the parsing breakdowns caused by center embedding. The model provides an algorithmic-level (Marr, 1982) account of […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.